These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 19877216

  • 21. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Charlton M, Seaberg E.
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
    [Abstract] [Full Text] [Related]

  • 22. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
    Ailawadi G, Smith PW, Oka T, Wang H, Kozower BD, Daniel TM, Kron IL, Jones DR.
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Induction therapy with OKT3 in pediatric liver-transplant recipients.
    Ryckman FC, Schroeder TJ, Pedersen SH, Dittrich VS, Balistreri WF.
    Transplant Sci; 1994 Dec; 4 Suppl 1():S20-5. PubMed ID: 7627451
    [Abstract] [Full Text] [Related]

  • 25. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K, Sandhu S, Wu C, Muirhead N, Hollomby D, Jevnikar A.
    Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
    [Abstract] [Full Text] [Related]

  • 26. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL, Jin XB, Li XT, Wang HW, Lü JJ.
    Chin Med J (Engl); 2009 Feb 20; 122(4):420-6. PubMed ID: 19302748
    [Abstract] [Full Text] [Related]

  • 27. Donor age and outcome of liver transplantation.
    Hoofnagle JH, Lombardero M, Zetterman RK, Lake J, Porayko M, Everhart J, Belle SH, Detre KM.
    Hepatology; 1996 Jul 20; 24(1):89-96. PubMed ID: 8707288
    [Abstract] [Full Text] [Related]

  • 28. Liver transplantation in the United States: a report from the UNOS Liver Transplant Registry.
    Smith CM, Davies DB, McBride MA.
    Clin Transpl; 1999 Jul 20; ():23-34. PubMed ID: 11038623
    [Abstract] [Full Text] [Related]

  • 29. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry.
    Donaldson PT, Thomson LJ, Heads A, Underhill JA, Vaughan RW, Rolando N, Williams R.
    Transplantation; 1995 Nov 15; 60(9):1016-23. PubMed ID: 7491675
    [Abstract] [Full Text] [Related]

  • 30. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
    LeFor WM, Wright CE, Bowers VD, Heinrichs DF, Shires DL.
    Clin Transpl; 1999 Nov 15; ():149-58. PubMed ID: 11038633
    [Abstract] [Full Text] [Related]

  • 31. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C, Lewin KJ, Busuttil RW, Martin P.
    Am J Gastroenterol; 1997 Sep 15; 92(9):1453-7. PubMed ID: 9317061
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
    Rayhill SC, Wu YM, Katz DA, Voigt MD, Labrecque DR, Kirby PA, Mitros FA, Kalil RS, Miller RA, Stolpen AH, Schmidt WN.
    Transplantation; 2007 Aug 15; 84(3):331-9. PubMed ID: 17700157
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Late acute rejection after liver transplantation impacts patient survival.
    Uemura T, Ikegami T, Sanchez EQ, Jennings LW, Narasimhan G, McKenna GJ, Randall HB, Chinnakotla S, Levy MF, Goldstein RM, Klintmalm GB.
    Clin Transplant; 2008 Aug 15; 22(3):316-23. PubMed ID: 18190550
    [Abstract] [Full Text] [Related]

  • 38. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM.
    Clin Transpl; 1997 Aug 15; ():1-14. PubMed ID: 9919387
    [Abstract] [Full Text] [Related]

  • 39. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching.
    Nikaein A, Backman L, Jennings L, Levy MF, Goldstein R, Gonwa T, Stone MJ, Klintmalm G.
    Transplantation; 1994 Oct 15; 58(7):786-92. PubMed ID: 7940711
    [Abstract] [Full Text] [Related]

  • 40. Frequency and severity of acute rejection in live- versus cadaveric-donor renal transplants.
    Campbell SB, Hothersall E, Preston J, Brown AM, Hawley CM, Wall D, Griffin AD, Isbel NM, Nicol DL, Johnson DW.
    Transplantation; 2003 Nov 27; 76(10):1452-7. PubMed ID: 14657685
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.